Fifty years devoted to anaerobes: historical, lessons, and highlights

Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the spe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical microbiology & infectious diseases 2024, Vol.43 (1), p.1-15
1. Verfasser: Dubreuil, Luc J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15
container_issue 1
container_start_page 1
container_title European journal of clinical microbiology & infectious diseases
container_volume 43
creator Dubreuil, Luc J.
description Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection. Prevotella , fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections, Bacteroides of the fragilis group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.
doi_str_mv 10.1007/s10096-023-04708-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2891750105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2891750105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EouXxBxhQJBaGBvyKH2yoagGpEgvMVmI7bao0Lr4pUv89hhaQGBiu73C-c651ELog-IZgLG8hvVrkmLIcc4lVzg_QkHBW5JxJdoiGWDOea0nZAJ0ALHEyKSmP0YBJLZnQbIgm06but9nWlxEy599D713Wh6zsSh9D5eEuWzTQh9jYsh1lrQcIHYyS7pIwX7RpejhDR3XZgj_f71P0Op28jB_z2fPD0_h-llsmiz7XljPOhSC2Zq6ipKpEwZ0W3BbK24phQq0TuHC1sEo6VZWOe0EV5spi5SU7Rde73HUMbxsPvVk1YH3blp0PGzBUaSILTHCR0Ks_6DJsYpd-Z6gmRFCqNU4U3VE2BoDoa7OOzaqMW0Ow-SzZ7Eo2qWTzVbLhyXS5j95UK-9-LN-tJoDtAEhSN_fx9_Y_sR_8joYZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2911622990</pqid></control><display><type>article</type><title>Fifty years devoted to anaerobes: historical, lessons, and highlights</title><source>Springer Nature - Complete Springer Journals</source><creator>Dubreuil, Luc J.</creator><creatorcontrib>Dubreuil, Luc J.</creatorcontrib><description>Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection. Prevotella , fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections, Bacteroides of the fragilis group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-023-04708-4</identifier><identifier>PMID: 37973693</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Accessibility ; Anaerobes ; Anaerobic treatment ; Antibiotic resistance ; Antibiotics ; Biomedical and Life Sciences ; Biomedicine ; Culture media ; Diaphragm ; Gram-positive cocci ; Identification methods ; Infections ; Internal Medicine ; Medical Microbiology ; Multidrug resistance ; Review</subject><ispartof>European journal of clinical microbiology &amp; infectious diseases, 2024, Vol.43 (1), p.1-15</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</citedby><cites>FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</cites><orcidid>0000-0001-6814-8739</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10096-023-04708-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10096-023-04708-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37973693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubreuil, Luc J.</creatorcontrib><title>Fifty years devoted to anaerobes: historical, lessons, and highlights</title><title>European journal of clinical microbiology &amp; infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection. Prevotella , fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections, Bacteroides of the fragilis group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.</description><subject>Accessibility</subject><subject>Anaerobes</subject><subject>Anaerobic treatment</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Culture media</subject><subject>Diaphragm</subject><subject>Gram-positive cocci</subject><subject>Identification methods</subject><subject>Infections</subject><subject>Internal Medicine</subject><subject>Medical Microbiology</subject><subject>Multidrug resistance</subject><subject>Review</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kDtPwzAUhS0EouXxBxhQJBaGBvyKH2yoagGpEgvMVmI7bao0Lr4pUv89hhaQGBiu73C-c651ELog-IZgLG8hvVrkmLIcc4lVzg_QkHBW5JxJdoiGWDOea0nZAJ0ALHEyKSmP0YBJLZnQbIgm06but9nWlxEy599D713Wh6zsSh9D5eEuWzTQh9jYsh1lrQcIHYyS7pIwX7RpejhDR3XZgj_f71P0Op28jB_z2fPD0_h-llsmiz7XljPOhSC2Zq6ipKpEwZ0W3BbK24phQq0TuHC1sEo6VZWOe0EV5spi5SU7Rde73HUMbxsPvVk1YH3blp0PGzBUaSILTHCR0Ks_6DJsYpd-Z6gmRFCqNU4U3VE2BoDoa7OOzaqMW0Ow-SzZ7Eo2qWTzVbLhyXS5j95UK-9-LN-tJoDtAEhSN_fx9_Y_sR_8joYZ</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Dubreuil, Luc J.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6814-8739</orcidid></search><sort><creationdate>2024</creationdate><title>Fifty years devoted to anaerobes: historical, lessons, and highlights</title><author>Dubreuil, Luc J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accessibility</topic><topic>Anaerobes</topic><topic>Anaerobic treatment</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Culture media</topic><topic>Diaphragm</topic><topic>Gram-positive cocci</topic><topic>Identification methods</topic><topic>Infections</topic><topic>Internal Medicine</topic><topic>Medical Microbiology</topic><topic>Multidrug resistance</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubreuil, Luc J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubreuil, Luc J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fifty years devoted to anaerobes: historical, lessons, and highlights</atitle><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2024</date><risdate>2024</risdate><volume>43</volume><issue>1</issue><spage>1</spage><epage>15</epage><pages>1-15</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection. Prevotella , fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections, Bacteroides of the fragilis group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37973693</pmid><doi>10.1007/s10096-023-04708-4</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0001-6814-8739</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0934-9723
ispartof European journal of clinical microbiology & infectious diseases, 2024, Vol.43 (1), p.1-15
issn 0934-9723
1435-4373
language eng
recordid cdi_proquest_miscellaneous_2891750105
source Springer Nature - Complete Springer Journals
subjects Accessibility
Anaerobes
Anaerobic treatment
Antibiotic resistance
Antibiotics
Biomedical and Life Sciences
Biomedicine
Culture media
Diaphragm
Gram-positive cocci
Identification methods
Infections
Internal Medicine
Medical Microbiology
Multidrug resistance
Review
title Fifty years devoted to anaerobes: historical, lessons, and highlights
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A08%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fifty%20years%20devoted%20to%20anaerobes:%20historical,%20lessons,%20and%20highlights&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Dubreuil,%20Luc%20J.&rft.date=2024&rft.volume=43&rft.issue=1&rft.spage=1&rft.epage=15&rft.pages=1-15&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-023-04708-4&rft_dat=%3Cproquest_cross%3E2891750105%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2911622990&rft_id=info:pmid/37973693&rfr_iscdi=true